A Dark Side of Calcium Channel Blockers: Increased Risk of Stasis Dermatitis.

The article focuses on the association between calcium channel blockers (CCBs) and the risk of developing stasis dermatitis (SD) in patients with essential hypertension. Using the TriNetX database, a retrospective cohort study compared SD outcomes over five years between patients treated with CCBs and those not prescribed these medications. The findings indicate that CCB use is significantly linked to an increased risk of SD in the lower extremities, potentially due to edema caused by the medications. The study suggests management strategies for patients experiencing SD, including dose adjustments or switching to alternative antihypertensive medications to mitigate the risk of venous congestion and inflammation. Limitations of the study include potential misclassification of SD diagnoses and residual confounding factors. [Extracted from the article]